4
Changes in Ownership
Vanda Pharmaceuticals Inc. Filed Acc 0001209191-23-016460
SVP, Business Development sold 16,777 shares at an average $6.23 ($104,584)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Birznieks Gunther SVP, Business Development | 2023-03-02 | Sale | −8,509 | $6.20 | $52,793 | 214,248 | D |
| Birznieks Gunther SVP, Business Development | 2023-03-03 | Sale | −8,268 | $6.26 | $51,791 | 205,980 | D |
| Open-market sales · 16,777 sh · avg $6.23 · $104,584 | |||||||
Loading xslF345X03/doc4.xml…